Apyx Medical Corporation (APYX)
APYX trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/719135/000143774926007471/0001437749-26-007471-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | APYX on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000719135 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $52.8M |
| Net income | -$11.2M |
| Operating income | -$6.4M |
| Net margin | -21.2% |
| Operating margin | -12.2% |
| Revenue growth | +9.9% |
| Cash | $31.7M |
| Total assets | $66.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 2.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-05 |
| Cash and burn | $25.8M cash; operating cash flow -$2.1M a quarter. | Report 2026-09-30 |
| Shares outstanding | 42,124,023 (2026-11-04); 38,241,905 a year earlier; 34,643,855 three years earlier. | Cover page 2026-11-04 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the market | Latest 2025-11-18 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | RSM US LLP, Tampa, Florida, United States | PCAOB Form AP 2026-03-20 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $14.0M | -$1.8M | -$1.6M | $25.8M | $37.5M | $59.6M | 10-Q 2026-11-05 |
| Q2 2026 2026-06-30 | $13.9M | -$3.2M | -$3.5M | $27.6M | $37.5M | $58.4M | 10-Q 2026-08-06 |
| Q1 2026 2026-03-31 | $12.5M | -$2.1M | -$572K | $31.1M | $37.5M | $55.9M | 10-Q 2026-05-07 |
| Q4 2025 2025-12-31 | $19.2M | -$1.3M | -$2.5M | $31.7M | $37.5M | $52.8M | 10-K 2026-03-10 |
| Q3 2025 2025-09-30 | $12.9M | -$2.0M | -$3.5M | $25.1M | $37.5M | $47.9M | 10-Q 2026-11-05 |
| Q2 2025 2025-06-30 | $11.4M | -$3.8M | -$1.2M | $29.3M | $37.5M | $46.5M | 10-Q 2026-08-06 |
| Q1 2025 2025-03-31 | $9.4M | -$4.2M | -$702K | $31.0M | $37.5M | $47.3M | 10-Q 2026-05-07 |
| Q4 2024 2024-12-31 | $14.2M | -$4.6M | -$2.9M | $31.7M | $37.5M | $48.1M | 10-K 2026-03-10 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2025-12-01 |
| Latest annual report FORM 10-K | 10-K | 2026-03-10 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-11-05 |
| Latest current report FORM 8-K | 8-K | 2026-11-05 |
| Latest proxy FORM DEF 14A | DEF 14A | 2026-06-26 |
Source: SEC EDGAR submissions feed, 992 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -4.1% |
| 1 month | +8.1% |
| 3 months | -7.6% |
| Year to date | -19.7% |
| 1 year | -31.0% |
| From 52-week high | -42.2% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SKYA | SkyAI Inc. | $2.11 | -9.05% | $107.3M |
| STIM | Neuronetics Inc. | $1.25 | -10.07% | $120.6M |
| LUNG | Pulmonx Corporation | $2.80 | -2.10% | $121.9M |
| PYPD | PolyPid Ltd. | $6.15 | -1.76% | $124.9M |
| SKIN | SkinHealth Systems Inc. | $15.05 | -7.73% | $98.5M |
| NYXH | Nyxoah SA | $0.8937 | -0.64% | $89.4M |
| LUCD | Lucid Diagnostics Inc. | $0.3978 | -11.42% | $82.3M |
| KRMD | KORU Medical Systems Inc. Common Stock (DE) | $3.69 | -0.27% | $160.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier